Physician profile

Mitchell D Kaplan

Periodontics · Ann Arbor, MI

NPI 1114018009

$2,875.83

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$634.62
Food and Beverage$18.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Acteon INC $1,908.00 2019
Hu-Friedy Mfg. Co., LLC $634.62 2024 Confirm10 In-Office Biological Monitoring System
Salvin Dental Specialties, INC. $157.69 2019-2020
Biohorizons Implant Systems INC. $150.93 2019-2023 Mineross Xp, Mineross X
Geistlich Pharma, North America, INC. $13.15 2019
Orapharma, A Division of Bausch Health US, LLC $11.44 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mitchell D Kaplan

$2,875.83

in general payments reported 2019-2025

Years
2019-2024
Top company
Acteon INC

https://glasscript.com/doctor/5609/mitchell-d-kaplan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.